Chronic Pain: New Zealand Launches Clinical Trial on Medical Cannabis and Sleep
Published
New Zealand will soon launch a clinical trial to study the effects of medical cannabis on sleep. The study concerns people who suffer from chronic back pain, a health problem that can seriously disrupt nights and quality of life.
Researchers want to find out whether medical cannabis can help patients sleep better. Sleep difficulties are common among people who have been in pain for a long time, as pain often prevents them from finding a comfortable position and resting properly. The trial will therefore measure the impact of the treatment on participants' sleep duration and quality.
This type of research is part of a broader debate on the use of cannabis for therapeutic purposes. In many countries, authorities require solid scientific evidence before approving these treatments. The results of the New Zealand study will therefore help to better understand the possible benefits, but also the potential risks.
In France, the use of medical cannabis remains strictly regulated and applies only to certain specific indications. The results of this trial could be of interest to specialists in pain and sleep, even though their application to other countries will need to be assessed with caution.
Sources: Newsweed
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy